Research Antibodies and Reagents Market by Product (Reagent [Sample Preparation (Media, Probe, Buffer), Antibody Production Reagent], Antibody [Type, Source, Research Area]), Technology (Western Blot, ELISA), Application, End User - Global Forecast to 2025

  • Report ID:MRHC - 104356
  • Pages: 280
  • Nov 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
          1.1.1. Research Antibodies and Reagents Market
          1.1.2. Research Antibodies and Reagents Market, by Product
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                    4.2.1.1. Rising Proteomics and Genomics Research Studies
                    4.2.1.2. Increase in the Funding for Research Activities
                    4.2.1.3. Growing Industry-Academia Collaboration
           4.2.2. Restraint
                    4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
           4.2.3. Opportunities
                    4.2.3.1. Rising Demand for Protein Therapeutics and Personalized Medicines
                    4.2.3.2. Rising Investment and Focus on Stem-Cell Research
                    4.2.3.3. Rising Need for New Biomarker Identification
                    4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
           4.2.4. Challenges
                    4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
                    4.2.4.2. Intense Pricing Pressure on Leading Players

5. Research Antibodies and Reagents Market, by Product
     5.1. Introduction
     5.2. Reagents
            5.2.1. Sample Preparation Reagents
                     5.2.1.1. Media and Serum
                     5.2.1.2. Stains and Dyes
                     5.2.1.3  Probes
                     5.2.1.4. Buffers
                     5.2.1.5. Solvents
            5.2.2. Antibody Production Reagents
                     5.2.2.1. Enzymes
                     5.2.2.2. Proteins
            5.2.3. Other Research Reagents
     5.3. Antibodies
            5.3.1. Antibodies Market, by Type
                     5.3.1.1. Primary Antibody
                     5.3.1.2. Secondary Antibody
            5.3.2. Antibodies Market, by Production Type
                     5.3.2.1. Monoclonal Antibody
                     5.3.2.2. Polyclonal Antibody
                     5.3.2.3. Antibody Fragments
            5.3.3. Antibody Market, by Source
                     5.3.3.1. Mouse
                     5.3.3.2. Rabbit
                     5.3.3.3. Other Sources
           5.3.4. Antibodies Market, by Research Area
                    5.3.4.1. Oncology
                    5.3.4.2. Infectious Diseases
                    5.3.4.3. Cardiovascular Disease
                    5.3.4.4. Immunology
                    5.3.4.5. Neurology
                    5.3.4.6. Stem Cell Research
                    5.3.4.7. Other Research Areas

6. Research Antibodies and Reagents Market, by Technology
    6.1. Introduction
    6.2  Western Blot
    6.3. Immunofluorescence
    6.4. Enzyme-Linked Immunosorbent Assay
    6.5. Multiplex Immunosorbent Assay
    6.6. Flow Cytometry
    6.8. Immunoprecipitation (IP)
    6.9. Other Technologies

7. Research Antibodies and Reagents Market, by Application
    7.1. Introduction
    7.2. Proteomics
    7.3. Drug Discovery and Development
    7.4. Genomics

8. Research Antibodies and Reagents Market, by End User
    8.1. Introduction
    8.2. Pharmaceutical and Biotechnology Industry
    8.3. Academics and Research Institutes
    8.4. Contract Research Organizations

9. Research Antibodies and Reagents Market, by Geography
    9.1. Introduction
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
   9.3. Europe
         9.3.1. Germany
         9.3.2. France
         9.3.3. U.K.
         9.3.4. Italy
         9.3.5. Spain
         9.3.6. Rest of Europe
   9.4. Asia-Pacific
         9.4.1. Japan
         9.4.2. China
         9.4.3. India
         9.4.4. Rest of Asia-Pacific
   9.5. Latin America
   9.6. Middle East & Africa

10. Competitive Landscape
      10.1. Introduction
      10.2. Key Growth Strategies
      10.3. Competitive Benchmarking
      10.4. Market Share Analysis (2018)

11. Company Profiles
      11.1. GE Healthcare
               11.1.1. Business Overview
               11.1.2. Financial Overview
               11.1.3. Product Portfolio
      11.2. Merck KGaA
              11.2.1. Business Overview
              11.2.2. Financial Overview
              11.2.3. Product Portfolio
              11.2.4. Strategic Developments
      11.3. Thermo Fisher Scientific Inc.
               11.3.1. Business Overview
               11.3.2. Financial Overview
               11.3.3. Product Portfolio
               11.3.4. Strategic Developments
      11.4. F. Hoffmann-La Roche Ltd
               11.4.1. Business Overview
               11.4.2. Financial Overview
               11.4.3. Product Portfolio
       11.5. Rockland Immunochemicals Inc.
               11.5.1. Business Overview
               11.5.2. Product Portfolio
       11.6. Johnson & Johnson (J&J)
               11.6.1. Business Overview
               11.6.2. Financial Overview
               11.6.3. Product Portfolio
       11.7. Eli Lilly and Company
               11.7.1. Business Overview
               11.7.2. Financial Overview
               11.7.3. Product Portfolio
      11.8. Teva Pharmaceutical Industries Limited
              11.8.1. Business Overview
              11.8.2. Financial Overview
              11.8.3. Product Portfolio
              11.8.4. Strategic Developments
      11.9. Abcam plc
               11.9.1. Business Overview
               11.9.2. Financial Overview
               11.9.3. Product Portfolio
               11.9.4. Strategic Developments
     11.10. Agilent Technologies, Inc.
               11.10.1. Business Overview
               11.10.2. Financial Overview
               11.10.3. Product Portfolio
     11.11. Cell Signaling Technology, Inc.
               11.11.1. Business Overview
               11.11.2. Product Portfolio
               11.11.3. Strategic Developments
     11.12. Becton Dickinson and Company
               11.12.1. Business Overview
               11.12.2. Financial Overview
               11.12.3. Product Portfolio
    11.13. Danaher Corporation
              11.13.1. Business Overview
              11.13.2. Financial Overview
              11.13.3. Product Portfolio
    11.14. Lonza
              11.14.1. Business Overview
              11.14.2. Financial Overview
              11.14.3. Product Portfolio
              11.14.4. Strategic Development
    11.15. PerkinElmer, Inc.
              11.15.1. Business Overview
              11.15.2. Financial Overview
              11.15.3. Product Portfolio
              11.15.4. Strategic Developments
    11.16. Genscript Biotech Corporation
              11.16.1. Business Overview
              11.16.2. Financial Overview
              11.16.3. Product Portfolio
              11.16.4. Strategic Developments
    11.17. Bio-Techne Corporation
              11.17.1. Business Overview
              11.17.2. Financial Overview
              11.17.3. Product Portfolio
              11.17.4. Strategic Developments
    11.18. Bio-Rad Laboratories, Inc.
               11.18.1. Business Overview
               11.18.2. Financial Overview
               11.18.3. Product Portfolio
               11.18.4. Strategic Developments
     11.19. Santa Cruz Biotechnology, Inc.
               11.19.1. Business Overview
               11.19.2. Product Portfolio
     11.20. BioLegend, Inc.
               11.20.1. Business Overview
               11.20.2. Product Portfolio
               11.20.3. Strategic Developments

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Global Research Antibodies and Reagents Market Drivers: Impact Analysis (2019-2025)
Table 2 Global Research Antibodies and Reagents Market Restraint: Impact Analysis (2019-2025)
Table 3 Global Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 4 Global Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 5 Global Research Reagents Market Size, by Country/Region, 2017-2025 ($Million)
Table 6 Global Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 7 Global Sample Preparation Reagents Market Size, by Country/Region, 2017-2025 ($Million)
Table 8 Global Media and Serum Market Size, by Country/Region, 2017-2025 ($Million)
Table 9 Global Stains and Dyes Market Size, by Country/Region, 2017-2025 ($Million)
Table 10 Global Probes Market Size, by Country/Region, 2017-2025 ($Million)
Table 11 Global Buffers Market Size, by Country/Region, 2017-2025 ($Million)
Table 12 Global Solvents Market Size, by Country/Region, 2017-2025 ($Million)
Table 13 Global Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 14 Global Antibody Production Reagents Market Size, by Country/Region, 2017-2025 ($Million)
Table 15 Global Enzymes Market Size, by Country/Region, 2017-2025 ($Million)
Table 16 Global Proteins Market Size, by Country/Region, 2017-2025 ($Million)
Table 17 Global Other Research Reagents Market Size, by Country/Region, 2017-2025 ($Million)
Table 18 Global Research Antibodies Market Size, by Country/Region, 2017-2025 ($Million)
Table 19 Global Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 20 Global Primary Antibodies Market Size, by Country/Region, 2017-2025 ($Million)
Table 21 Global Secondary Antibodies Market Size, by Country/Region, 2017-2025 ($Million)
Table 22 Global Research Antibodies Market Size, by Production Type, 2017-2025 ($Million)
Table 23 Global Monoclonal Antibodies Market Size, by Country/Region, 2017-2025 ($Million)
Table 24 Global Polyclonal Antibodies Market Size, by Country/Region, 2016-2023 ($Million)
Table 25 Global Antibody Fragments Market Size, by Country/Region, 2017-2025 ($Million)
Table 26 Global Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 27 Global Mouse Derived Antibodies Market Size, by Country/Region, 2019-2025 ($Million)
Table 28 Global Rabbit Derived Antibodies Market Size, by Country/Region, 2017-2025 ($Million)
Table 29 Global Other Sources Derived Antibodies Market Size, by Country/Region, 2017-2025 ($Million)
Table 30 Global Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 31 Global Research Antibodies Market Size for Oncology, by Country/Region, 2019-2025 ($Million)
Table 32 Global Research Antibodies Market Size for Infectious Diseases, by Country/Region, 2017-2025 ($Million)
Table 33 Global Research Antibodies Market Size for Cardiovascular Diseases, by Country/Region, 2017-2025($Million)
Table 34 Global Research Antibodies Market Size for Immunology, by Country/Region, 2017-2025 ($Million)
Table 35 Global Research Antibodies Market Size for Neurology, by Country/Region, 2017-2025($Million)
Table 36 Global Research Antibodies Market Size for Stem Cell Research, by Country/Region, 2017-2025 ($Million)
Table 37 Global Research Antibodies Market Size for Other Research Areas, by Country/Region, 2017-2025 ($Million)
Table 38 Global Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 39 Global Research Antibodies and Reagents Market Size for Western Blot, by Country/Region, 2017-2025 ($Million)
Table 40 Global Research Antibodies and Reagents Market Size for Immunofluorescence, by Country/Region, 2017-2025 ($Million)
Table 41 Global Research Antibodies and Reagents Market Size for Enzyme-Linked Immunosorbent Assay, by Country/Region, 2017-2025 ($Million)
Table 42 Global Multiplex Immunosorbent Assay Market Size, by Country/Region, 2017-2025 ($Million)
Table 43 Global Research Antibodies and Reagents Market Size for Flow Cytometry, by Country/Region, 2017-2025 ($Million)
Table 44 Global Research Antibodies and Reagents Market Size for Immunohistochemistry, by Country/Region, 2017-2025 ($Million)
Table 45 Global Research Antibodies and Reagents Market Size for Immunoprecipitation, by Country/Region, 2017-2025 ($Million)
Table 46 Global Research Antibodies and Reagents Market Size for Other Technologies, by Country/Region, 2017-2025 ($Million)
Table 47 Global Research Antibodies and Reagents Market Size, by Application, 2016-2023 ($Million)
Table 48 Global Research Antibodies and Reagents Market Size for Proteomics, by Country/Region, 2017-2025 ($Million)
Table 49 Global Research Antibodies and Reagents Market Size for Drug Discovery and Development, by Country/Region, 2017-2025 ($Million)
Table 50 Global Research Antibodies and Reagents Market Size for Genomics, by Country/Region, 2017-2025 ($Million)
Table 51 Global Research Antibodies and Reagents Market Size, by End User, 2017-2025 ($Million)
Table 52 Global Research Antibodies and Reagents Market Size for Pharmaceutical and Biotechnology Industry, by Country/Region, 2019-2025 ($Million)
Table 53 Global Research Antibodies and Reagents Market Size for Academic and Research Institutes, by Country/Region, 2019-2025 ($Million)
Table 54 Global Research Antibodies and Reagents Market Size for Contract Research Organizations, by Country/Region, 2017-2025 ($Million)
Table 55 Global Research Antibodies and Reagents Market Size, by Country/Region, 2017-2025 ($Million)
Table 56 North America: Research Antibodies and Reagents Market Size, by Country, 2017-2025 ($Million)
Table 57 North America: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 58 North America: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 59 North America: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 60 North America: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 61 North America: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 62 North America: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 63 North America: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 64 North America: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 65 North America: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 66 North America: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 67 North America: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 68 U.S.: Key Macroindicators
Table 69 U.S.: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 70 U.S.: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 71 U.S.: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 72 U.S.: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 73 U.S.: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 74 U.S.: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 75 U.S.: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 76 U.S.: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 77 U.S.: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 78 U.S.: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 79 U.S.: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 80 Canada: Key Macroindicators
Table 81 Canada: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 82 Canada: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 83 Canada: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 84 Canada: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 85 Canada: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 86 Canada: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 87 Canada: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 88 Canada: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 89 Canada: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 90 Canada: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 91 Canada: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 92 Europe: Research Antibodies and Reagents Market Size, by Country, 2017-2025 ($Million)
Table 93 Europe: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 94 Europe: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 95 Europe: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 96 Europe: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 97 Europe: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 98 Europe: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 99 Europe: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 100 Europe: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 101 Europe: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 102 Europe: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 103 Europe: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 104 Germany: Key Macroindicators
Table 105 Germany: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 106 Germany: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 107 Germany: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 108 Germany: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 109 Germany: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 110 Germany: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 111 Germany: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 112 Germany: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 113 Germany: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 114 Germany: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 115 Germany: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 116 France: Key Macroindicators
Table 117 France: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 118 France: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 119 France: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 120 France: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 121 France: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 122 France: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 123 France: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 124 France: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 125 France: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 126 France: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 127 France: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 128 U.K.: Key Macroindicators
Table 129 U.K.: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 130 U.K.: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 131 U.K.: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 132 U.K.: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 133 U.K.: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 134 U.K.: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 135 U.K.: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 136 U.K.: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 137 U.K.: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 138 U.K.: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 139 U.K.: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 140 Italy: Key Macroindicators
Table 141 Italy: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 142 Italy: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 143 Italy: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 144 Italy: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 145 Italy: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 146 Italy: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 147 Italy: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 148 Italy: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 149 Italy: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 150 Italy: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 151 Italy: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 152 Spain: Key Macroindicators
Table 153 Spain: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 154 Spain: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 155 Spain: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 156 Spain: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 157 Spain: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 158 Spain: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 159 Spain: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 160 Spain: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 161 Spain: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 162 Spain: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 163 Spain: Research Antibodies and Reagents Market Size, By End User, 2016-2023 ($Million)
Table 164 RoE: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 165 RoE: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 166 RoE: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 167 RoE: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 168 RoE: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 169 RoE: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 170 RoE: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 171 RoE: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 172 RoE: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 173 RoE: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 174 RoE: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 175 Asia Pacific: Research Antibodies and Reagents Market Size, by Country, 2017-2025 ($Million)
Table 176 Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 177 Asia-Pacific: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 178 Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 179 Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 180 Asia-Pacific: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 181 Asia-Pacific: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 182 Asia-Pacific: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 183 Asia-Pacific: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 184 Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 185 Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 186 Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 187 Japan: Key Macroindicators
Table 188 Japan: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 189 Japan: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 190 Japan: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 191 Japan: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 192 Japan: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 193 Japan: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 194 Japan: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 195 Japan: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 196 Japan: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 197 Japan: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 198 Japan: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 199 China: Key Macroindicators
Table 200 China: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 201 China: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 202 China: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 203 China: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 204 China: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 205 China: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 206 China: Research Antibodies Market Size, By Source, 2017-2025 ($Million)
Table 207 China: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 208 China: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 209 China: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 210 China: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 211 India: Key Macroindicators
Table 212 India: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 213 India: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 214 India: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 215 India: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 216 India: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 217 India: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 218 India: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 219 India: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 220 India: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 221 India: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 222 India: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 223 RoAPAC: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 224 RoAPAC: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 225 RoAPAC: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 226 RoAPAC: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 227 RoAPAC: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 228 RoAPAC: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 229 RoAPAC: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 230 RoAPAC: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 231 RoAPAC: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 232 RoAPAC: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 233 RoAPAC: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 234 Latin America: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 235 Latin America: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 236 Latin America: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 237 Latin America: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 238 Latin America: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 239 Latin America: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 240 Latin America: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 241 Latin America: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 242 Latin America: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 243 Latin America: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 244 Latin America: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 245 Middle East & Africa: Research Antibodies and Reagents Market Size, by Product, 2017-2025 ($Million)
Table 246 Middle East & Africa: Research Reagents Market Size, by Type, 2017-2025 ($Million)
Table 247 Middle East & Africa: Sample Preparation Reagents Market Size, by Type, 2017-2025 ($Million)
Table 248 Middle East & Africa: Antibody Production Reagents Market Size, by Type, 2017-2025 ($Million)
Table 249 Middle East & Africa: Research Antibodies Market Size, by Type, 2017-2025 ($Million)
Table 250 Middle East & Africa: Research Antibodies Market Size, by Production, 2017-2025 ($Million)
Table 251 Middle East & Africa: Research Antibodies Market Size, by Source, 2017-2025 ($Million)
Table 252 Middle East & Africa: Research Antibodies Market Size, by Research Area, 2017-2025 ($Million)
Table 253 Middle East & Africa: Research Antibodies and Reagents Market Size, by Technology, 2017-2025 ($Million)
Table 254 Middle East & Africa: Research Antibodies and Reagents Market Size, by Application, 2017-2025 ($Million)
Table 255 Middle East & Africa: Research Antibodies and Reagents Market Size, by End User, 2016-2023 ($Million)
Table 256 Number of Developments by the Major Players during 2016-2019

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Reagents Dominate the Global Research Antibodies and Reagents Market
Figure 6 Global Research Antibodies and Reagents Market, by Technology, 2019-2025 ($Million)
Figure 7 Global Research Antibodies and Reagents Market, by Application, 2019-2025 ($Million)
Figure 8 Pharmaceutical and Biotechnology Industry Segment is Expected to be a Prominent End User for Research Antibodies and Reagents Market
Figure 9 Research Antibodies and Reagents Market, by Region
Figure 10 Rate of Publication Related to Genomics, Proteomics or Metabolomics (2008-2016)
Figure 11 Share of Medical and Health R&D Expenditure of U.S. by Type Of Organization: 2017
Figure 12 Number of Therapeutic Proteins Approved Globally, 2012-2015
Figure 13 NIH Spending on Stem Cell Research in U.S. (2013-2016)
Figure 14 Number of New Cancer Cases Globally: 2012-2040
Figure 15 Proportion of Population Aged 60 Or Over in Asia, By Region, 2016-2050
Figure 16 Monoclonal Antibody Approval Rate (2008-2015)
Figure 17 Global Research Antibodies and Reagents Market Size, by Product, 2019-2025 ($Million)
Figure 18 Number of Cancer Cases and Deaths Globally: 2018-2040
Figure 19 Global Number of People Living with HIV in 2017 (In Millions)
Figure 20 Number of Deaths Attributed to Cardiovascular Disease Globally, 2013-2030 (In Millions)
Figure 21 Global Research Antibodies and Reagents Market Size, by Technology, 2019-2025 ($Million)
Figure 22 Global Research Antibodies and Reagents Market Size, by Application, 2019-2025 ($Million)
Figure 23 Number of Biologics Approved by U.S. FDA: 2010-2018
Figure 24 Global Research Antibodies and Reagents Market Size, by End User, 2019-2025 ($Million)
Figure 25 Global Research Antibodies and Reagents Market Size, by Geography, 2019-2025 ($Million)
Figure 26 Number of Geriatric Population (65 Years & Above) in the U.S., 2010-2060 (Millions)
Figure 27 North America: Research Antibodies and Reagents Market Size, by Country, 2019-2025 ($Million)
Figure 28 Number of People with Chronic Diseases in America.: 2005-2030 (Million)
Figure 29 Pharma Member Company R&D Expenditure in U.S., 2005-2017 ($Billion)
Figure 30 Cancer Cases in Canada: 2018-2040
Figure 31 Population Aged 60 or Over in Europe: 2017 And 2050
Figure 32 Health Spending ($/Capita), by G7 Countries- 2018
Figure 33 Europe: Research Antibodies and Reagents Market Size, by Country, 2019-2025 ($Million)
Figure 34 Biotechnology Firms in Germany: 2010-2017
Figure 35 Share of Population Aged 65 & Above in Total Population in France: 2010-2018
Figure 36 Number of New Cancer Cases and Mortality in U.K.:2018-2040
Figure 37 Number of Biotech Firms in Italy: 2008-2017
Figure 38 Cancer Incidence by Country: 2018-2040 (Number of Cases)
Figure 39 Asia-Pacific: Research Antibodies and Reagents Market Size, by Country, 2019-2025 ($Million)
Figure 40 Population Aged 60 Or Over in Japan (As % of Total Population): 2000-2030
Figure 41 Cancer Incidence in Latin America & Caribbean, 2018-2040 (Number of Cases)
Figure 42 Cancer Incidence in Middle East and Africa: 2012 And 2030
Figure 43 Key Growth Strategies Adopted by Leading Players, 2016-2019
Figure 44 Research Antibodies and Reagents Market: Competitive Benchmarking
Figure 45 Global Research Antibodies Market Share, by Key Players, 2018
Figure 46 GE Healthcare: Financial Overview (2016-2018)
Figure 47 Merck KgaA: Financial Overview (2016-2018)
Figure 48 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
Figure 49 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018)
Figure 50 Johnson & Johnson: Financial Overview (2016-2018)
Figure 51 Eli Lilly and Company: Financial Overview (2016-2018)
Figure 52 Teva Pharmaceuticals Industries Limited: Financial Overview (2016-2018)
Figure 53 Abcam plc: Financial Overview (2017-2019)
Figure 54 Agilent Technologies, Inc.: Financial Overview (2016-2018)
Figure 55 Becton, Dickinson and Company: Financial Overview (2016-2018)
Figure 56 Danaher Corporation: Financial Overview (2016-2018)
Figure 57 Lonza: Financial Overview (2016-2018)
Figure 58 PerkinElmer, Inc.: Financial Overview (2016-2018)
Figure 59 Genscript Biotech Corporation: Financial Overview (2016-2018)
Figure 60 Bio-Techne Corporation: Financial Overview (2017-2019)
Figure 61 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)


The global research antibodies and reagents market is expected to grow at a CAGR of 6% from 2019 to 2025 to reach $14.56 billion by 2025. Due to high specificity, binding affinity, long half-lives, and low toxicity, antibodies are considered as an effective tool for research, diagnostic, and therapeutic purposes. Antibodies are invaluable reagents for antigen detection and purification, which includes immunoblotting, immunoprecipitation, immunohistochemistry, and more. The growth in this market is majorly driven by rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations.

Increase in funding for research activities is propelling the growth of research antibodies and reagents market

According to Research America, investment in medical and health research and development by the U.S. has increased by 18.1% between 2014 and 2017. In 2017, total expenditure on medical and health R&D in the U.S. was $182.3 billion. Pharmaceutical, medical technology, biotechnology, and health IT companies, accounted for the largest share of the U.S. investment in medical and health R&D over the reporting period.

Similarly, in Europe, according to the European Union (EU), the government launched program Horizon 2020 in 2016, with an investment of $88.5 billion (€80 billion), of which around 10% (~$9 billion) was utilized for healthcare sector. The initiative was aimed to develop and support personalized medicine projects. Also, during the period of 2014–2016, the European Commission invested more than $2.7 billion (€2.4 billion) in projects that supported innovation in personalized medicine.

Rising demand for protein therapeutics and personalized medicine supports the market growth

The recent developments in protein purification technologies and expression systems have increased the production of therapeutic peptides while maintaining product safety or efficacy or both at the same time. Due to this, the number of therapeutic peptides approvals has grown almost three-fold from 6 in 2012 to 17 in 2015. Similarly, according to the Personalized Medicine Coalition (PMC), globally, number of commercially available personalized medicines in the market has increased steadily from 5 in 2008 to 148 in number in 2017. Government initiatives for development of personalized medicines are offering significant growth opportunities for research antibodies and reagents market.

Research Antibodies and Reagents Market

Click here to: Get Free Sample Pages of this Report

Key Findings in the Global Research Antibodies and Reagents Market Study:

Reagents accounted for large share of the research antibodies and reagents market

Due to recurrent use of reagents in many research assays and techniques, increasing use of reagents to understand molecular basis of diseases, and routine use of reagents in target-based assays, the demand for reagents is high. This accounts for large share of reagents in the market.

Antibodies & reagents for Western blotting to witness the largest demand through 2025

Western Blot segment is estimated to command the largest share of the global research antibodies and reagents market in 2019 due to rising research funding for biomarker discovery, surge in antibody & cell-based research, and high demand for effective test kits to detect causative agents for viral diseases. Owing to these, the adoption of antibodies for western blotting is consistently increasing, globally.

Proteomic segment to dominate the global research antibodies and reagents market by 2025

Proteomics segment is estimated to command the largest share of the overall research antibodies and reagents market in 2019. This was mainly attributed to the increase in search for ideal candidates for use as anti-cancer drugs, need for designing more effective drugs, assessment of drug efficacy and patient response, and increasing investments for development of personalized medicines.

Pharmaceutical and biotechnology industry to dominate the overall research antibodies and reagents market

Pharmaceutical and biotechnology industry segment is estimated to command the largest share of the overall research antibodies and reagents market in 2019. Increasing investments on research activities, rising adoption of research antibodies & reagents in the proteomics research and drug discovery programs, and growing demand for effective personalized medicine are some of the major factors driving the growth of this market. In addition, increasing R&D spending by pharmaceutical and biotechnology industry, globally is also driving the adoption of research antibodies and reagents in pharmaceutical and biotechnology industry.

Asia-Pacific: The fastest-growing regional market

North America is estimated to command the largest share of the global research antibodies and reagents market in 2019, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific region will be the fastest growing regional market due to accelerated economic growth of many countries in this region; increasing incidence of chronic diseases, and growing government focus towards improvement of healthcare sector. In addition, government initiatives and investments in drug development programs to design targeted medicines are further propelling the growth of the Asia-Pacific research antibodies and reagents market.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global research antibodies and reagents market report are Abcam plc (U.K.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland),  Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc.(U.S.).

Scope of the Report:

Research Antibodies and Reagents Market, by Product

  • Reagents
    • Sample Preparation Reagents
      • Media & Serum
      • Stains & Dyes
      • Probes
      • Buffers
      • Solvents
    • Antibody Production Reagents
      • Enzymes
      • Proteins
    • Other Research Reagents
      (Note: Other research reagents include fixatives, preservatives, gels, and reagent preloaded membranes)
  • Antibodies
    • Antibodies Market, by Type
      • Primary Antibody
      • Secondary Antibody
    • Antibodies Market, by Production Type
      • Monoclonal Antibody
      • Polyclonal Antibody
      • Antibody Fragments
    • Antibodies Market, by Source
      • Mouse
      • Rabbit
      • Other Sources
        (Note: Other sources include as goat, sheep, chicken, and human)
    • Antibodies Market, by Research Area
      • Oncology
      • Infectious Diseases
      • Cardiovascular Disease
      • Immunology
      • Neurology
      • Stem Cell Research
      • Other Research Areas
        (Note: Other research areas include as ophthalmology and rare diseases)

Research Antibodies and Reagents Market, by Technology

  • Western Blot
  • Immunofluorescence
  • Immunohistochemistry
  • Flow Cytometry
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Multiplex Immunosorbent Assay
  • Immunoprecipitation
  • Other Technologies
    (Note: Other technologies includeelectrophoretic mobility shift assay (EMSA) and enzyme linked immunospot)

Research Antibodies and Reagents Market, by Application

  • Proteomics
  • Drug discovery & Development
  • Genomics

Research Antibodies and Reagents Market, by End User

  • Pharmaceutical & Biotechnology Industry
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Research Antibodies and Reagents Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
    • Latin America
  • Middle East & Africa

Key questions answered in the report-

Increase in the funding for research activities will propel the research antibodies and reagents market

  • How does the increase in funding influence the adoption ofresearch antibodies and associated reagents?
  • How are the leading players benefitted from the increasing research funding?

Pharmaceutical and biotechnology industry accounted for the largest share of the research antibodies and reagents market

  • What factors are contributing to the frequent usage of research antibodies and reagents in pharmaceutical and biotechnology industry?
  • What is the pharmaceutical & biotechnology industry growth scenario in different regions?
  • How does the penetration of research antibodies and reagents in pharmaceutical and biotechnology industry differ from other end users?

The North American research antibodies and reagents market favors both larger and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market use to compete effectively?
  • What are the major drivers, restraints, opportunities, and challenges, in the global research antibodies and reagents market?
  • What are the geographical trends and high growth regions/ countries?

Leading market players are increasingly focusing on different growth strategies to strengthen their market position

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the research antibodies and reagents market?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global research antibodies and reagents market and what share of the market do they hold?
  • Who are the local emerging players in the global research antibodies and reagents market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare
Download Free Sample